Optimas Capital
TEVA icon

Optimas Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Optimas Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-163,400
Closed -$2.51M – 29
2025
Q1 		$2.51M Buy
+163,400
New +$2.92M 4.27% 9

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Ion Asset Management
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Optimas Capital's TEVA Position: Q2 2025 in Review

Optimas Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2025, closing a stake of 163,400 shares — an estimated $2.51M sold.

Optimas Capital first reported a position in TEVA in Q1 2025 and held it in 1 quarter. The position peaked at $2.51M in Q1 2025. 544 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • Optimas Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2025 after selling out during the quarter.
  • Optimas Capital sold 163,400 Teva Pharmaceutical Industries Limited shares in Q2 2025, an estimated $2.51M.
  • Optimas Capital first reported a position in Teva Pharmaceutical Industries Limited in Q1 2025 and held it in 1 quarter.
  • Optimas Capital's Teva Pharmaceutical Industries Limited position peaked at $2.51M in Q1 2025.
  • 544 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2025.

Based on Optimas Capital's 13F filing for Q2 2025, filed 13 Aug 2025.